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Abstract
Background: Hospital readmission rate is receiving increasing regulatory scrutiny. Patients with cirrhosis have high hospital
readmissions rates but the relationship between frequent readmissions and barriers to transplantation remains unexplored.
The goal of this study was to determine risk factors for frequent readmissions among patients with cirrhosis and identify
barriers to transplantation in this population.
Methods:We retrospectively reviewed medical records of 587 patients with a confirmed diagnosis of cirrhosis admitted to a
large tertiary care center between May 1, 2008 and May 1, 2009. Demographics, clinical factors, and outcomes were
recorded. Multivariate logistic regression was performed to identify risk factors for high readmission rates. Transplant-
related factors were assessed for patients in the high readmission group.
Results: The 587 patients included in the study had 1557 admissions during the study period. A subset of 87 (15%) patients
with 5 or more admissions accounted for 672 (43%) admissions. The factors associated with frequent admissions were non-
white race (OR = 2.45, p = 0.01), diabetes (OR= 2.04, p = 0.01), higher Model for End-Stage Liver Disease (MELD) score
(OR= 35.10, p,0.0001 for MELD.30) and younger age (OR= 0.98, p = 0.02). Among the 87 patients with $5 admissions,
only 14 (16%) underwent liver transplantation during the study period. Substance abuse, medical co-morbidities, and low
(,15) MELD scores were barriers to transplantation in this group.
Conclusions: A small group of patients with cirrhosis account for a disproportionately high number of hospital admissions.
Interventions targeting this high-risk group may decrease frequent hospital readmissions and increase access to
transplantation.
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Introduction
The high frequency and cost of readmissions are important
factors underlying the increase in healthcare costs in the United
States (US). Recent studies have demonstrated that 20% of
Medicare beneficiaries are re-hospitalized within 30 days and 34%
within 90 days and the majority have medical rather than surgical
indications for admission [1]. The estimated cost of unplanned
readmissions was $17.4 billion in 2004, which comprised 20% of
Medicare’s hospital payments [1,2]. Therefore, readmission rates
have been proposed as a national quality indicator and the search
for modifiable risk factors for readmissions is considered critical to
limiting healthcare spending [3].
Cirrhosis leads to over 150,000 hospitalizations at an annual
cost of nearly $4 billion in the US [4–6]. A recent study found
that the readmission rate among patients with cirrhosis-related
complications was 20% at 30 days [7]. Another study found a
30-day readmission rate of 37% among patients with decom-
pensated cirrhosis with an overall rate of 3 hospitalizations per
person-year [8]. Since the prevalence of end-stage liver disease
is expected to increase due to the increasing burden of hepatitis
C- and non-alcoholic fatty liver disease, hospitalizations from
complications of cirrhosis and the associated risk of readmissions
are also likely to increase [9–12].
Attempts to decrease frequency of readmissions in patients
with cirrhosis are likely to be most cost-effective if they are
directed towards patients at the highest risk of readmissions.
Thus, we sought to identify risk factors for frequent admissions
in cirrhosis patients that may be amenable to targeted
interventions. Furthermore, since liver transplantation is the
only definitive therapy available for decompensated cirrhosis, we
hypothesized that patients with frequent readmissions have
significant barriers to liver transplantation. We show here that a
relatively small group of cirrhosis patients accounts for a
surprisingly large number of hospital admissions and identify
potential barriers to transplantation in this cohort.
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Methods
We queried electronic medical records at the University of
Pittsburgh Medical Center and identified 1,802 patients admitted
with the ICD-9 code 571 (chronic liver disease and cirrhosis)
between May 1, 2008 and May 1, 2009. After review of each
patient’s chart by an experienced hepatologist, 823 patients were
excluded because they did not have cirrhosis based on imaging
studies, liver biopsy, or clinical documentation of a cirrhosis-
related complication. To ensure adequate time for follow-up and
opportunity for frequent readmissions as well as to homogenize the
length of follow-up, 211 patients who did not have at least 90 days
of follow-up were also excluded. Patients with total parenteral
nutrition (TPN)-induced liver failure (N= 11), fulminant liver
failure (N= 44), metastatic or neuroendocrine tumors of the liver
(N= 43), prior liver transplant (N= 24), and death or transplant
during the index admission (N= 59) were also excluded. Thus, a
total of 587 patients with confirmed cirrhosis admitted during the
study period were included in the final analysis.
The mean number of admissions per person-year in this cohort
was 4.25, based on which we divided the patients into the
following two groups: those with 4 or fewer admissions (including
the initial admission) and those with 5 or more admissions (the
‘‘high-readmission’’ group). Baseline characteristics were calculat-
ed for both groups. The etiology of cirrhosis was categorized as
due to alcohol, viral hepatitis (with or without alcohol), or other
and then as alcohol-related or non-alcohol related. The reason for
initial admission was categorized as cirrhosis-related vs. non-
cirrhosis related. Among patients with cirrhosis-related admissions,
reasons for readmission were categorized as fluid-related (includ-
ing ascites, hydrothorax, or renal failure related to liver disease),
encephalopathy-related and bleeding-related (esophageal or gas-
tric variceal bleeding). The fluid-related problems were collapsed
to allow sufficient numbers for inclusion in multivariate regression
models. Length of follow-up was calculated for each person from
the date of discharge after the index admission until the end of the
study period or death. T-tests were used to compare continuous
variables, and Chi-square test for categorical variables. For non-
normal data, medians and interquartile ranges were calculated
and Wilcoxon-Rank Sum test was used for comparisons of
medians. Fisher’s exact test was used to compare categorical
variables with expected cell counts of less than 5.
A logistic regression model was created to compare patients
with 5 or more admissions to those with ,5 admissions using
variables from baseline characteristics with p,0.2 in comparisons
and using dummy variables for a priori categories of MELD
scores. Race was coded as white vs. non-white for the purposes of
logistic regression. The reason for index admission was coded into
dummy variables including encephalopathy and volume-related
admissions. Length of follow up was included in the model to
account for differences, and this variable accounted for time of
death. Odds ratios, p values, and 95% confidence intervals were
calculated for each variable, and variance inflation factors were
checked in the final model to ensure there was no multi-
collinearity. To create the most parsimonious model, variables
were removed in a backward elimination fashion until only
significant predictors remained (p,0.05). To control for bias
introduced by excluding those with,90 days of follow-up, we also
tested a similar model by including these individuals in the
analysis. To check the assumptions of the model and avoid picking
a cut-point for number of admissions, a linear regression model
was created. All covariates were included in the initial model, and
a stepwise backwards elimination was completed to leave a
parsimonious model with covariates with p,0.1 remaining.
For the 87 patients in the high-readmission group, change in
MELD score from the first to the last admission was calculated,
and this was used to calculate change in MELD per person per
month of follow up. To identify the barriers to liver transplant in
this group, we reviewed their charts to ascertain dates of transplant
referral, listing, and (if applicable) the reason for their not being
referred or listed. The mean number of admissions between
referral and listing was calculated for the patients who were
evaluated for liver transplantation. The mean time between
referral and listing was also calculated for patients that were listed
for transplant.
Ethics Statement
Prior approval for this study was obtained from the University
of Pittsburgh Medical Center Quality Improvement Committee.
The study was conducted as a consent-waived quality improve-
ment project with adherence to all ethical and patient confiden-
tiality standards of our institution.
Results
The 587 cirrhosis patients included in the study had a total of
1,557 admissions during the one-year study period. The mean
number of admissions per person-year was 4.2563.8, with a mean
absolute number of admissions of 2.762.6. A group of 87 patients
with 5 or more admissions made up 15% of the study group but
contributed 43% (n= 672) of the admissions (high-readmission
group; Figure 1).
Patients in the high-readmission group were younger and more
likely to be non-white (Table 1). They were also more likely to
have diabetes, higher baseline MELD scores, and alcohol-related
cirrhosis. The mean length of follow up was 232 days in the low-
readmission (4 or less total admission) group vs. 281 days in the
high-readmission group. The follow-up time difference between
the groups was 1.5 months, compared to a median time of follow-
up of 9 months. Marital and family situations were similar between
the groups. The reason for initial admission in the high-
readmission group was more likely to be related to a complication
of cirrhosis and more likely to be specifically related to hepatic
encephalopathy or volume-related issue (ascites, hydrothorax,
and/or renal failure). The high-readmission group had longer
initial length of stay and was more likely to die or undergo liver
transplantation during the study period.
In the final logistic regression model (Table 2), high readmis-
sions rate was associated with younger age and non-white race
Figure 1. A small group of cirrhosis patients accounts for a
dispropionate percentage of hospital admissions. The percent-
age of patients with one or more admissions during the study period is
shown.
doi:10.1371/journal.pone.0055140.g001
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(OR=2.45, 95%CI= 1.19, 4.94). Diabetes also increased the odds
of admissions (OR=2.04, 95%CI= 1.18, 3.54). The high-read-
mission group had significantly higher MELD scores. The mean
change in MELD over the study period was 0.8764.75 points with
a median change of 0 (range=28 to 18, IQR=22,3). The
change per month was 0.1460.78, with a median change of 0
(range =22 to 2.6, IQR=20.3 to 0.34). A logistic regression
model was made including those with ,90 day follow-up, and the
median follow-up time was expectedly more disparate between
those with and without at least 5 admissions (median 286 vs 174
days). By including patients with ,90 days of follow-up, only 3
additional patients were added to the high-readmission group and
the final model was similar to that obtained by excluding patients
with short follow-up time. However, age and cirrhosis-related
index admission became non-significant, and alcohol-related
etiology of liver disease became a significant factor.
Since liver transplantation is an important indication for
patients with decompensated cirrhosis, we determined potential
barriers to transplantation for patients in the high-readmission
group (Figure 2). Just 14 (16%) patients in this group underwent
liver transplantation during the study period and an additional
9 (10%) patients were active on the transplant list, including
6 patients that had MELD score ,15. Eight (9%) patients were
listed for transplant but either died (5 patients) or inactivated from
the transplant list due to acute illness or deconditioning
(3 patients). The mean time for all patients between referral to
Table 1. Comparison of baseline characteristics based on number of admissions.
Characteristics
Less than 5 total admissions
(N=500)
5 or more total admissions
(N=87) P value
Age* 56.7612.6 53.1612.0 0.01
Male gender N (%) 278 (56) 39 (45) 0.97
Race N (%) 0.022+
Caucasian 438 (88) 69 (79)
African-American 44 (9) 15 (17)
Other 4 (1) 2 (2)
Married N (%) 270 (54) 41 (47) 0.28
Diabetes 52 (10) 35 (40) 0.03
BMI* 26.565.3 27.366.2 0.43
Etiology of Liver Disease 0.24
Alcohol 121 (24) 28 (32)
Viral +/2 Alcohol 176 (35) 25 (29)
Other 203 (41) 34 (39)
Alcohol-related etiology 139 (28) 34 (39) 0.045
MELD score N (%) ,0.0001
,15 276 (55) 12 (14)
15–20 141 (28) 44 (51)
21–30 79 (16) 27 (31)
31–40 4 (1) 4 (5)
MELD score index admission* 14.466.0 19.164.8 ,0.0001
Blood Type 0.39 2+
O 180 (36) 35 (40)
A 155 (31) 31 (36)
B 46 (9) 10 (11)
AB 7 (1) 4 (5)






Non-cirrhosis-related index admission 248 (50) 22 (26) ,0.0001
Encephalopathy-related index admission 74 (15) 21 (24) 0.04
Volume-related index admission** 91 (18) 31 (36) 0.0004
Bleeding-related index admission 38 (8) 6 (7) 0.99
Length of follow up (days)* 232+82 281670 ,0.0001
Death during study N (%) 28 (6) 14 (16) 0.001
Transplant during study N (%) 30 (6) 14 (16) 0.002
*Mean 6 sd, p value calculated using t-test.
2+Fisher’s Exact test used, numbers do not sum to 100% given missing values.
**Volume-related index admission = renal failure, ascites, or hydrothorax.
doi:10.1371/journal.pone.0055140.t001
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listing was 2046247 days, with a median of 111 days. The 9
patients that were both referred and listed for transplant in the
study period had an average of 1.3 (range 0–3) admissions between
referral and listing.
Fifty-six (64%) of 87 patients in the high-readmission group
were deemed unsuitable candidates for transplantation. Nine of
these patients died during the study period. Barriers to transplan-
tation in this group of patients included active alcohol and drug
use with or without psychiatric co morbidities in 13 (15%) patients,
low MELD score (,15) in 11 (20%) patients, and medical
comorbidities, advanced age, inoperable hepatocellular carcino-
ma, or extra hepatic cancers in the remainder. Two patients were
not listed for transplant due to lack of health insurance.
Discussion
As the debate over healthcare costs intensifies and the issue of
hospital readmission rates gets increased regulatory scrutiny, it is
important to identify patients who may benefit from targeted
interventions to decrease the risk of readmissions. Our study
makes three important contributions to the field. First, to the best
of our knowledge, our study is the first to show that in a cohort of
patients (cirrhotics) at high risk of hospitalization, a relatively small
group accounts for a disproportionate number of readmissions.
Second, we demonstrate that racial disparities may be contributing
to the risk of readmissions in patients with cirrhosis. We also
corroborate previous studies that MELD score and diabetes are
factors increasing risk of readmission in patients with cirrhosis.
Third, we establish that cirrhosis patients with frequent readmis-
sion have significant barriers to transplantation that could
potentially be targeted to increase access to transplantation and
mitigate the high readmission rates.
Recent studies demonstrate that early re-hospitalizations among
patients with decompensated cirrhosis are common, with 20–37%
of patients being readmitted within 1 month of discharge [7,8].
Early readmission was associated with MELD score, diabetes, and
male gender, while the time to readmission in another study was
predicted by MELD score, serum sodium level, and number of
medications on discharge [8]. In patients with hepatitis C-related
cirrhosis, readmission rate at 1-year was 45% with a remarkably
high admission rate of 73% among patients with hepatic
encephalopathy [12]. Taken together, these studies strongly
suggest that the prevention of hospital readmissions in patients
with end-stage liver disease represents a major unmet healthcare
need deserving of the same level of attention from the healthcare
Table 2. Final logistic regression model comparing
characteristics of those with 5 or more admissions to those
with less admission.
Variable OR 95% CI P
Age 0.98 0.95, 0.996 0.02
Non-white race 2.45 1.19, 4.94 0.01
Diabetes 2.04 1.18, 3.54 0.01
MELD score (vs.
those 14 or less)
15–20 6.55 3.35, 13.68 ,0.0001
21–30 8.58 4.12, 18.88 ,0.0001
31–40 35.10 6.82, 186.29 ,0.0001
Length follow up* 1.01 1.005,1.01 ,0.0001
*Follow up time was from the index discharge to the end of the study period or
to time of death.
doi:10.1371/journal.pone.0055140.t002
Figure 2. Flowchart showing transplant-related outcomes in patients with .4 admissions. Patients deemed to not to be transplant
candidates include both referred and non-referred patients. Low MELD score patients had MELD ,15.
doi:10.1371/journal.pone.0055140.g002
Cirrhosis and Risk of Readmissions
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community that has been accorded to patients with chronic
obstructive pulmonary disease or congestive heart failure. Chronic
disease management is now a widely accepted to address chronic
disease outcomes in patients with heart disease and diabetes [13].
However, while inconsistency of care of cirrhosis has been well-
recognized and quality indicators have been put forth for cirrhosis
care [14], chronic disease management in cirrhotics has not been
well studied or established. The goal of our study was to identify
cirrhosis patients at high risk of frequent hospital admissions and
identify potential barriers to liver transplantation.
That patients with decompensated cirrhosis have high readmis-
sion rates would by itself not be surprising. However, a significant
finding of our study was that a relatively small number of patients
(not necessarily the medically sickest patients as assessed by
conventional scoring criteria) accounted for a disproportionately
large percentage of hospital admissions in this population. We
found that MELD score was a strong predictor of frequent hospital
admissions, a finding that is consistent with prior reports and with
the MELD score as being a validated predictor of prognosis in
patients with cirrhosis. In addition, race and diabetes were
associated with frequent admissions. Prior studies have shown that
African-Americans having the highest rates of preventable
hospitalization for congestive heart failure, diabetes, and hyper-
tension [15–17]. Whether these findings are also true for patients
with cirrhosis will require further research, including controlling
for potential confounders of educational and socioeconomic status
[15,18–21]. Diabetes alone does not explain the racial disparity in
readmission; given that race was still a factor despite controlling
for diabetes. Given the increased risk of frequent admissions in
patients with diabetes, our results raise the question whether better
control of diabetes could be a potential intervention in this
population to decrease hospitalization. Prior studies have shown
that diabetes is also a risk factor for hepatic encephalopathy and
may have contributed to frequent hospitalizations in these patients
[22,23]. Our study has implications for clinical practice for
healthcare providers as well for hospital administrators, policy
makers, and health insurance companies who make decisions
regarding allocation of resources towards the care of these
patients.
Since liver transplantation is now considered an important
therapeutic option in patients with advanced liver disease, we were
interested in determining potential barriers to transplantation in
the group of patients at the highest risk of admissions. Not
surprisingly, we found that this group had significant barriers to
transplantation, including active alcohol use and addiction issues.
Thus, our results raise the possibility that targeting this group for
early and aggressive intervention directed at addiction and
psychiatric comorbidities may be an option to decrease hospital-
izations and increase access to transplantation. Interestingly,
several patients in this group, despite their obviously advanced
liver disease, had low MELD scores (,15). Since MELD score of
great than 15 is required in the US for deceased donor
transplantation, this subgroup represents unique challenges to
manage their disease. Thus, it is intriguing to speculate whether
interventions such as early transjugular intrahepatic portosystemic
shunt placement in patients with cirrhosis, special considerations
in the organ allocation system, or live donor liver transplant in
patients with ascites would decrease the frequency of admissions in
this group of patients and provide overall more cost-effective care
[24–26]. Our study identifies groups of patients who are ineligible
for liver transplant and at high risk for admissions towards which
specific, personalized interventions can be targeted to minimize
risk of hospitalization. Indeed, insights gained from our study has
led to changes in practice patterns at our institution, including
early referral to drug and alcohol treatment programs, aggressive
management of fluid status in patients identified on their index
admission to be at risk of readmission, and more timely referrals to
palliative care.
Some limitations of our study should be considered. We did not
have data on education or socioeconomic status to control for
potential confounders in terms of the differences we saw in terms
of race. Since the goal our study was to discover risk factors for
multiple readmissions, time-based analyses could not be used.
Therefore, we controlled for non-uniform follow-up interval by
including follow-up time in the model. In order to minimize the
differences in follow-up time, patients with less than 90 days of
follow-up were excluded from the study. Excluding these patients
could potentially lead to bias, therefore, we also analyzed the data
by including the group with shorter follow-up times and the
predictive factors remained the same and just 3 additional patients
were included in the hyper-admission group. The choice of 5
admissions for the cut-off was based on the both on the mean
number of admissions per person year as well as the fact that this
group accounted for half of the total admissions in the study group.
These results are of particular interest because we show that
targeting this small group of patients and optimizing their
transplant status could potentially decrease the risk of half of all
admissions.
In summary, a relatively small number of patients with end-
stage liver disease account for a disproportionately large number
of hospital admissions. Diabetes, race, and MELD score were
predictive of high risk of admissions. In this group of patients at the
highest risk of admissions significant barriers to transplant exist.
Interventions designed to address these factors, including low
MELD score despite having decompensated cirrhosis and
addiction issues could potentially increase access to transplantation
and decrease frequency of hospitalizations.
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